![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Prostate Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Prostate Cancer is free of charge.
Beyond the AJR: Biparametric MRI-Based Prostate Cancer Screening-A Cost-Effective
Alternative to PSA Screening and Standard Biopsy.
AJR Am J Roentgenol. 2023 Jan 18. doi: 10.2214/AJR.23.29011.
PubMed
Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at
high genetic risk.
BJU Int. 2023 Jan 17. doi: 10.1111/bju.15968.
PubMed
Abstract available
Metabolic syndrome and its components predict the biochemical recurrence and
adverse pathological features of patients following radical prostatectomy: a
propensity score matching study.
BMC Cancer. 2023;23:50.
PubMed
Abstract available
High-throughput precision MRI assessment with integrated stack-ensemble deep
learning can enhance the preoperative prediction of prostate cancer Gleason
grade.
Br J Cancer. 2023 Jan 17. doi: 10.1038/s41416-022-02134.
PubMed
Abstract available
Semiautomated pelvic lymph node treatment response evaluation for patients with
advanced prostate cancer: based on MET-RADS-P guidelines.
Cancer Imaging. 2023;23:7.
PubMed
Abstract available
Automated deep-learning system in the assessment of MRI-visible prostate cancer:
comparison of advanced zoomed diffusion-weighted imaging and conventional
technique.
Cancer Imaging. 2023;23:6.
PubMed
Abstract available
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer
Cells of Disparate Origin Independently of Androgen Receptor Signaling.
Cancer Res. 2023;83:219-238.
PubMed
Abstract available
Editorial Comment on a national questionnaire survey of Japanese urologists on
active surveillance for low- and intermediate-risk prostate cancer.
Int J Urol. 2023 Jan 18. doi: 10.1111/iju.15142.
PubMed
Safety of hydrogel spacers for rectal wall protection in patients with prostate
cancer: A retrospective analysis of 200 consecutive cases.
Int J Urol. 2023 Jan 18. doi: 10.1111/iju.15140.
PubMed
Abstract available
Editorial for "Deep-Learning Models for Detection and Localization of Visible
Clinically Significant Prostate Cancer on Multi-Parametric MRI".
J Magn Reson Imaging. 2023 Jan 20. doi: 10.1002/jmri.28609.
PubMed
Consecutive PSMA and AR PET imaging shows positive correlation to AR and PSMA
protein expression in primary hormone naive prostate cancer.
J Nucl Med. 2023 Jan 19:jnumed.122.264981. doi: 10.2967/jnumed.122.264981.
PubMed
Abstract available
Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet's Ilioinguinal
Lymph Node. Reply.
J Urol. 2023 Jan 19:101097JU0000000000003178. doi: 10.1097/JU.0000000000003178.
PubMed
Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet's Ilioinguinal
Lymph Node. Letter.
J Urol. 2023 Jan 17:101097JU0000000000003177. doi: 10.1097/JU.0000000000003177.
PubMed
Prostate cancer lesion detection, volume quantification and high-grade cancer
differentiation using cancer risk maps derived from multiparametric MRI with
histopathology as the reference standard.
Magn Reson Imaging. 2023 Jan 11:S0730-725X(23)00007.
PubMed
Abstract available
The future of patient-derived xenografts in prostate cancer research.
Nat Rev Urol. 2023 Jan 17. doi: 10.1038/s41585-022-00706.
PubMed
Abstract available
Do cancer detection rates differ between transperineal and transrectal
micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity
score-matched study.
PLoS One. 2023;18:e0280262.
PubMed
Abstract available
Androgen deprivation therapy in men with prostate cancer is not associated with
COVID-2019 infection.
Prostate. 2023 Jan 19. doi: 10.1002/pros.24485.
PubMed
Abstract available
Holmium laser enucleation of the prostate in men on active surveillance for
prostate cancer with refractory lower urinary tract symptoms secondary to
enlarged prostates.
Prostate. 2023 Jan 19. doi: 10.1002/pros.24487.
PubMed
Docetaxel versus abiraterone for metastatic hormone-sensitive prostate cancer
with focus on efficacy of sequential therapy.
Prostate. 2023 Jan 20. doi: 10.1002/pros.24488.
PubMed
Abstract available
Metabolic Phenotyping of Prostate Cancer Using Hyperpolarized (13)C MRI.
Radiol Imaging Cancer. 2023;5:e239001.
PubMed
Imaging Neuroendocrine Prostate Cancer with (89)Zr-labeled Delta-Like Ligand 3.
Radiol Imaging Cancer. 2023;5:e239002.
PubMed
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by